Corporate Round - Innate Pharma - Oct 24, 2018 Funding Round Profile - Cointime

Bitcoin $93,635.73 -1.91%
Ethereum $3,363.60 +1.39%
BNB $684.63 +4.32%
Optimism $1.83 +3.07%
Arbitrum $0.78 +2.98%
Solana $185.59 +1.94%
Polygon $0.48 +0.68%
Cosmos $6.62 +1.25%
Avalanche $37.27 -0.22%

Bitcoin $93,635.73 -1.91%
Ethereum $3,363.60 +1.39%
BNB $684.63 +4.32%
Optimism $1.83 +3.07%
Arbitrum $0.78 +2.98%
Solana $185.59 +1.94%
Polygon $0.48 +0.68%
Cosmos $6.62 +1.25%
Avalanche $37.27 -0.22%

Innate Pharma

company

Funding Round

Corporate Round

Money Raised

€ 62.60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
AstraZeneca	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 1, 2004	Series C	€ 15M	Novo Nordisk,Akka Venture,etc.	Detail
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail